Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Neurobiol Aging. 2017 Jun 24;58:239.e1–239.e7. doi: 10.1016/j.neurobiolaging.2017.06.010

Table 1.

Participant characteristics by genetic status

Variable GBA carriers (n = 28) Noncarriers (n = 708) p-value
Gender (%female) 61% 64.3% 0.121a
Age at baseline, y, mean (SD) 77.4 (5.6) 78.5 (5.3) 0.339b
Education, y, mean (SD) 14.6 (3.8) 14.0 (3.4) 0.484b
Follow-up visits, mean (SD), median 3.72 (1.85), 4 6.13 (3.80), 6 0.000b
Follow-up discontinued 25 (89.3%) 594 (83.9%) 0.444a
 Developed dementia 7 (25.0%) 107 (15.1%) 0.156a
 Developed PD 1 (3.7%) 11 (1.6%) 0.408a
 Deceased 7 (25.0%) 239 (33.8%) 0.335a
 Withdrew 9 (32.1%) 136 (19.2%) 0.160a
 Lost to follow up 1 (3.7%) 101 (14.3%) 0.108a
FCSRT, mean (SD) 32.0 (5.1) 30.7 (6.3) 0.172
UPDRS-III, mean (SD) 6.1 (6.0) 7.8 (6.9) 0.431

Key: FCSRT, free and cued selective reminding test; SD, standard deviation; UPDRS-III, Unified Parkinson’s Disease Rating Scale motor section; y, years.

a

Chi-squared test.

b

Mann Whitney U test.